Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 2/20 | 0.52 |
| ▸ | AKT1 | P31749 | 12/20 | 0.52 |
| ▸ | MTOR | P42345 | 11/20 | 0.52 |
| ▸ | ACP1 | P24666 | 1/20 | 0.45 |
| ▸ | PIK3CA | P42336 | 7/20 | 0.44 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | USP8 | P40818 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.43 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.43 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.43 |
| ▸ | PRKDC | P78527 | 1/20 | 0.43 |
| ▸ | PIK3C3 | Q8NEB9 | 1/20 | 0.43 |
| ▸ | CSNK1D | P48730 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3522354 | 0.89 | LMNA (0.46) | AKT1MTORHPGDMAPK1 | |
| SCHEMBL3521451 | 0.88 | EPHX2 (0.42) | DYRK1AAKT1MTORACP1PIK3CA | |
| SCHEMBL3523578 | 0.88 | AKT1 (0.51) | DYRK1AAKT1MTORPIK3CAHPGD | |
| SCHEMBL3524710 | 0.86 | AKT1 (0.50) | DYRK1AAKT1MTORACP1PIK3CA | |
| SCHEMBL3524989 | 0.84 | AKT1 (0.50) | DYRK1AAKT1MTORPIK3CAHPGD | |
| SCHEMBL3525396 | 0.83 | ALDH1A1 (0.44) | AKT1MTORPIK3CA | |
| SCHEMBL3520224 | 0.83 | TRPV1 (0.45) | DYRK1AUSP2USP8MAPK1 | |
| SCHEMBL3524774 | 0.80 | ALDH1A1 (0.41) | — | |
| SCHEMBL3524894 | 0.79 | ALDH1A1 (0.42) | AKT1MTORPIK3CA | |
| SCHEMBL3527568 | 0.79 | TRPV1 (0.43) | DYRK1AUSP2USP8MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8436040-B2 | Method of treating conditions involving PPAR-receptors with indole compounds | LABORATOIRES FOURNIER S.A. (FR) | 2013-05-07 | — | — | US | disclosed |
| US-20100286137-A1 | Method of Treating Conditions Involving PPAR-Receptors with Indole Compounds | LABORATORIES FOURNIER S.A. (FR) | 2010-11-11 | — | — | US | disclosed |
| US-7795297-B2 | Indole compounds, method of preparing them and uses thereof | LABORATORIES FOURNIER S.A. (FR) | 2010-09-14 | — | — | US | disclosed |
| US-20080153816-A1 | Indole Compounds, Method of Preparing Them and Uses Thereof | LABORATOIRES FOURNIER S.A. (FR) | 2008-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080153816-A1 | Indole Compounds, Method of Preparing Them and Uses Thereof | LIPG, GPR119, IAPP | DYRK1A 1276/4885AKT1 974/4885MTOR 672/4885 |
| US-20100286137-A1 | Method of Treating Conditions Involving PPAR-Receptors with Indole Compounds | GPR119, PPARA, PPARG | DYRK1A 1708/4885AKT1 1496/4885MTOR 1509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.